Dolutegravir And Lamivudine Combination For The Treatment Of HIV-1 Infection

Código QR

Dolutegravir And Lamivudine Combination For The Treatment Of HIV-1 Infection

Francis J Zamora,1,2 Ellen Dowers,2 Faiza Yasin,3 Onyema Ogbuagu3 1Department of Pharmacy Services, Broward Health Medical Center, Fort Lauderdale, FL, USA; 2Department of Pharmacy Services, Yale-New Haven Hospital, New Haven, CT, USA; 3Section of Infectious Diseases, Yale AIDS Program, Yale Univers...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Zamora FJ, Dowers E, Yasin F, Ogbuagu O
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2019
Materias:	dolutegravir lamivudine combination antiretroviral therapy Immunologic diseases. Allergy RC581-607
Acceso en línea:	https://doaj.org/article/134e70daf0d848d3b33efb2378bc5b49
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Dolutegravir/rilpivirine for the treatment of HIV-1 infection
por: Dowers E, et al.
Publicado: (2018)

EXPERIENCE WITH DOLUTEGRAVIR IN HIV PATIENTS AT A PUBLIC SECTOR HOSPITAL IN KARACHI, PAKISTAN
por: Farzana Batool, et al.
Publicado: (2021)

Profile of once-daily darunavir/cobicistat fixed-dose combination for the treatment of HIV/AIDS
por: Navarro J, et al.
Publicado: (2016)

Effect of Lamivudine on the Rat Pregnancy Outcome
por: Pontes,Rosana Dorsa Vieira, et al.
Publicado: (2005)

Antiretroviral therapy interruptions: impact on HIV treatment and transmission
por: Dubrocq G, et al.
Publicado: (2018)

Factors associated with antiretroviral therapy adherence among people living with HIV in Haiti: a cross-sectional study
por: Ludentz Dorcélus, et al.
Publicado: (2021)

Antiretroviral Treatment Adherence and Determinant Factors Among Adult People Infected with Human Immunodeficiency Virus in Eastern Tigray General Hospitals, Northern Ethiopia, 2019
por: Gebreagziabher TT, et al.
Publicado: (2020)

Prevalence and Factors Associated with Delayed Initiation of Antiretroviral Therapy Among People Living with HIV in Nekemte Referral Hospital, Western Ethiopia
por: Bayisa L, et al.
Publicado: (2020)

Profile of cabotegravir and its potential in the treatment and prevention of HIV-1 infection: evidence to date
por: Whitfield T, et al.
Publicado: (2016)

Evaluating cabotegravir/rilpivirine long-acting, injectable in the treatment of HIV infection: emerging data and therapeutic potential
por: Fernandez C, et al.
Publicado: (2019)

The Effect of Moderate- and High-Fat Meals on the Bioavailability of Dolutegravir/Rilpivirine Fixed-Dose Combination Tablet
por: Mehta R, et al.
Publicado: (2020)

Elevation of immunoglobulin levels is associated with treatment failure in HIV-infected children in Vietnam
por: Dang LVP, et al.
Publicado: (2018)

CLINICAL EFFICIENCY AND INFLUENCE OF COMBINED ANTIHYPERTENSIVE THERAPY UPON CYTOKINE PROFILE IN THE PATIENTS WITH ARTERIAL HYPERTENSION
por: T. A. Dronova, et al.
Publicado: (2014)

ROLE OF HEPATITIS C VIRUS COINFECTION IN VIOLATION OF PRODUCTIVE THYMIC FUNCTION IN HIV-INFECTED PATIENTS UNDER IMMUNOLOGICALLY INEFFICIENT ANTIRETROVIRAL THERAPY
por: E. V. Saidakova, et al.
Publicado: (2014)

Experiences and Lessons Learnt from the HIV Treat All Pilot Phase Implementation in Zimbabwe
por: Makurumidze R
Publicado: (2021)

Doravirine and Its Potential in the Treatment of HIV: An Evidence-Based Review of the Emerging Data
por: Rock AE, et al.
Publicado: (2020)

Potential benefit of dolutegravir once daily: efficacy and safety
por: Fantauzzi A, et al.
Publicado: (2013)

Antiretroviral Therapy – Changes of Basic Laboratory Parameters in Hiv-Infected Bulgarian Patients
por: Stojanova Yancheva Nina
Publicado: (2015)

APPLICATION OF HIGH-PERFORMANCE THIN-LAYER CHROMATOGRAPHIC METHOD FOR THE SIMULTANEOUS DETERMINATION OF LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE IN PHARMACEUTICAL DOSAGE FORM
por: CHANDRA,P, et al.
Publicado: (2011)

Incidence and Predictors of Initial Antiretroviral Therapy Regimen Change Among HIV-Infected Adults Receiving Antiretroviral Therapy at Arba Minch General Hospital, Southern Ethiopia
por: Gebremichael MA, et al.
Publicado: (2020)

Dyslipidemia and Associated Factors Among Adult Patients on Antiretroviral Therapy in Armed Force Comprehensive and Specialized Hospital, Addis Ababa, Ethiopia
por: Kemal A, et al.
Publicado: (2020)

Exploring Self-Management of Adults Living with HIV on Antiretroviral Therapy in North-West Ethiopia: Qualitative Study
por: Areri H, et al.
Publicado: (2020)

Evaluation of the Sociodemographic, Behavioral and Clinical Influences on Complete Antiretroviral Therapy Adherence Among HIV-Infected Adults Receiving Medical Care in Houston, Texas
por: Sok P, et al.
Publicado: (2021)

Antiretroviral Treatment Failure and Associated Factors Among HIV-Infected Children on Antiretroviral Therapy: A Retrospective Study
por: Getawa S, et al.
Publicado: (2021)

Adherence to Antiretroviral Treatment Among People Who Started Treatment on the Same-Day of HIV Diagnosis in Ethiopia: A Multicenter Observational Study
por: Ahmed I, et al.
Publicado: (2021)

Antiretroviral Therapy and Retention in Care Experiences and Needs of Adolescents Living with HIV in Southern Ethiopia
por: Tunje A, et al.
Publicado: (2021)

Patient Satisfaction with HIV and AIDS Services in Mizan-Tepi University Teaching Hospital, Southwest Ethiopia
por: Nigussie T, et al.
Publicado: (2020)

Trends, treatment outcomes, and determinants for attrition among adult patients in care at a large tertiary HIV clinic in Nairobi, Kenya: a 2004–2015 retrospective cohort study
por: Mecha JO, et al.
Publicado: (2018)

Antiretroviral Therapy-Associated Metabolic Complications: Review of the Recent Studies
por: Thet D, et al.
Publicado: (2020)

Serum Lipid Profiles of Patients Taking Efavirenz-Based Antiretroviral Regimen Compared to Ritonavir-Boosted Atazanavir with an Optimized Background at Zewditu Memorial Hospital, Addis Ababa, Ethiopia
por: Muche Belete A, et al.
Publicado: (2021)

Mother-to-Child Transmission of HIV and Its Predictors Among HIV-Exposed Infants at an Outpatient Clinic for HIV/AIDS in Vietnam
por: Nguyen RN, et al.
Publicado: (2020)

Influence of Lost to Follow Up from Antiretroviral Therapy Among Retroviral Infected Patients at Tuberculosis Centers in Public Hospitals of Benishangul-Gumuz, Ethiopia
por: Degavi G
Publicado: (2021)

Patient Reported Central Nervous System Adverse Events of Efavirenz-Based Antiretroviral Therapy in People Living with HIV in Northwest Ethiopia
por: Muche EA, et al.
Publicado: (2020)

Reply to Das and Berkhout, “How Polypurine Tract Changes in the HIV-1 RNA Genome Can Cause Resistance against the Integrase Inhibitor Dolutegravir”
por: Isabelle Malet, et al.
Publicado: (2018)

Safety and effectiveness of switching to Abacavir/Lamivudine plus rilpivirine for maintenance therapy in virologically suppressed HIV-1 individuals in Singapore (SEALS)
por: Z. C. Lim, et al.
Publicado: (2021)

Prevalence of Opportunistic Intestinal Parasitic Infections Among HIV/AIDS Patients Before and After Commencement of Antiretroviral Treatment at Felege Hiwot Referral Hospital: A Follow-up Study
por: Getachew T, et al.
Publicado: (2021)

Regulatory T cell subsets in peripheral blood of HIV-infected patients with discordant response to antiretroviral therapy
por: L. B. Korolevskaya, et al.
Publicado: (2020)

First-line antiretroviral treatment failure and associated factors in HIV patients at University of Gondar Teaching Hospital, Gondar, Northwest Ethiopia
por: Ayalew MB, et al.
Publicado: (2016)

Incidence and Predictors of Severe Adverse Drug Reaction Among Patients on Antiretroviral Therapy in Tigray, Ethiopia: A Retrospective Cohort Study
por: Gebremeskel TG, et al.
Publicado: (2021)

Attrition and Its Predictors Among Adults Receiving First-Line Antiretroviral Therapy in Woldia Town Public Health Facilities, Northeast Ethiopia: A Retrospective Cohort Study
por: Dejen D, et al.
Publicado: (2021)